• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX SA VIDAS® LYME IGG

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX SA VIDAS® LYME IGG Back to Search Results
Catalog Number 417401
Device Problem False Negative Result (1225)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Event Description
A customer from the united states notified biomérieux of false negative results associated with the vidas® lyme igg ii involving a patient sample.The customer indicated running the patient sample and getting negative result; however, the sample was sent to a reference lab where the western blot was positive for multiple bands.The customer reported the specimen they tested and the specimen the reference lab tested were obtained from the patient at the same time but were in different tubes.Serum was used for both tests.The customer indicated neither specimen is available for submission to biomérieux.A biomérieux investigation will be initiated.
 
Manufacturer Narrative
A customer from the united states had notified biomérieux of false negative results associated with the vidas® lyme igg ii involving a patient sample.An internal biomérieux investigation was performed.The patient sample was not submitted for evaluation.The analysis of batch history records for vidas lyme igg ii lot 1005659490 /180710 0 showed no anomaly during the manufacturing and control processes.The analysis of control charts of eight (8) internal samples, three (3) negative, five (5) positive, on seven (7) vidas lyme igg ii batches (including lot mentioned by customer) showed that all the results were within specifications.Vidas lyme igg ii lot 1005659490 /180710 0 is in the trend of the other batches.The complaint laboratory tested five (5) internal samples (five (5) positive) on a retained kit of vidas lyme igg ii lot 1005659490 /180710 0.The results obtained were within the expected specifications and similar to those obtained during release.There is no drift of vidas lyme igg ii lot 1005659490 /180710 0 since its release.As it was not possible to get the sample, no further investigation could be performed.Vidas lyme igg ii lot 1005659490 /180710 0 performed within the expected specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS® LYME IGG
Type of Device
VIDAS® LYME IGG
Manufacturer (Section D)
BIOMERIEUX SA
chemin de l orme
marcy l etoile, rhone 69280
FR 
MDR Report Key7076042
MDR Text Key94743631
Report Number3002769706-2017-00390
Device Sequence Number1
Product Code LSR
UDI-Device Identifier03573026458270
UDI-Public03573026458270
Combination Product (y/n)N
PMA/PMN Number
K141133
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup
Report Date 03/02/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/10/2018
Device Catalogue Number417401
Device Lot Number1005659490
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 11/07/2017
Initial Date FDA Received12/01/2017
Supplement Dates Manufacturer Received02/06/2018
Supplement Dates FDA Received03/02/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-